Blue Fin Capital’s VanEck Biotech ETF BBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $241K | Buy |
+1,570
| New | +$241K | 0.04% | 137 |
|
|
2024
Q4 | $246K | Sell |
1,570
-53
| -3% | -$8.32K | 0.05% | 126 |
|
|
2024
Q3 | $288K | Hold |
1,623
| – | – | 0.05% | 125 |
|
|
2024
Q2 | $273K | Sell |
1,623
-24
| -1% | -$4.04K | 0.05% | 130 |
|
|
2024
Q1 | $274K | Sell |
1,647
-138
| -8% | -$23K | 0.06% | 128 |
|
|
2023
Q4 | $295K | Sell |
1,785
-799
| -31% | -$132K | 0.08% | 117 |
|
|
2023
Q3 | $402K | Sell |
2,584
-149
| -5% | -$23.2K | 0.12% | 97 |
|
|
2023
Q2 | $427K | Hold |
2,733
| – | – | 0.12% | 97 |
|
|
2023
Q1 | $434K | Hold |
2,733
| – | – | 0.14% | 95 |
|
|
2022
Q4 | $437K | Sell |
2,733
-427
| -14% | -$68.2K | 0.16% | 90 |
|
|
2022
Q3 | $444K | Hold |
3,160
| – | – | 0.17% | 87 |
|
|
2022
Q2 | $460K | Sell |
3,160
-111
| -3% | -$16.2K | 0.16% | 88 |
|
|
2022
Q1 | $530K | Buy |
+3,271
| New | +$530K | 0.15% | 85 |
|